Levosimendan use in patients with acute heart failure and reduced ejection fraction with or without severe renal dysfunction in critical cardiac care units: a multi-institution database study
Clicks: 84
ID: 266796
2021
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
24.9
/100
84 views
12 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #111 of 131 articles by views in annals of intensive care
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 131 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Acute heart failure is a life-threatening clinical condition. Levosimendan is an effective inotropic agent used to maintain cardiac output, but its usage is limited by the lack of evidence in patients with severely abnormal renal function. Therefore, ...
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (37 words).
Try re-searching for a better abstract.
| Reference Key |
chu2021annalslevosimendan
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Cze-Ci Chan, Kuang-Tso Lee, Wan-Jing Ho, Yi-Hsin Chan, Pao-Hsien Chu;Cze-Ci Chan;Kuang-Tso Lee;Wan-Jing Ho;Yi-Hsin Chan;Pao-Hsien Chu; |
| Journal | annals of intensive care |
| Year | 2021 |
| DOI |
10.1186/s13613-021-00810-y
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.